AzTrials
AzTrials

MyopiaNCT05715424

Community Intervention and Demonstration Area Construction

A study testing Six interventions for children and adolescents in people with Myopia and Refractive Errors, run by Anhui Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Myopia, Refractive Errors
What is being tested?
Six interventions for children and adolescents
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000,000 participants
Where
1 siteChina
Study dates
1 Dec 2022to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • ● Kindergarten kids.
  • Grade of 1 to 6 in elementary schools.
  • Grade of 1 to 3 in middle schools.
  • Grade of 1 to 3 in high schools.
  • Sign the informed consent.

Who cannot join

  • ●Visual defect or other eye diseases.
  • wearing orthokeratology; refractive surgery history.
  • Not considered suitable for inclusion in the study by the investigator.

Trial locations and contacts

1 site in 1 country.

FangBiao Tao, Professor contact

+86 19966513010

vipur8@outlook.com

China1 site, 1 recruiting
  • Anqing myopia scene

    Anqing, Anhui, 246000

    XiangLin Zhang, 19966513010, 1696061680@qq.com

    Recruiting

Other trials in China

About this study

Official title: Research on Precise Myopia Prevention and Control Technology and Demonstration Application for Children and Adolescent

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. The study will be conducted in the form of a stepped intervention and will answer the following questions.

Current China children and adolescent's vision health, including the different degrees of myopia prevalence, and farsightedness reserve status. To evaluate the implementation and effect of eight appropriate technologies and six interventions developed in this study, to reduce the incidence of myopia among children and adolescents in China, to achieve the purpose of nationwide application.

In the early stage of this study, a baseline survey will be conducted on participants. In the middle stage, participants will be required to adjust the seat height regularly and increase the time for outdoor activities, etc. In the later stage, intervention measures will be evaluated based on the overall research situation to consider national promotion.

Being tested
Six interventions for children and adolescents
Medical subject headings
Myopia, Refractive Errors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Six interventions for children and adolescentsOther

    • Vision Health Record Establishment and Myopia Risk Assessment.
    • Evaluation of vision care behavior and development of reasonable eye use behavior.
    • Health education for teachers and parents.
    • Action to improve the reading and writing environment at home and school.
    • One hour of outdoor activities in and out of school during the day.
    • Myopia grading management and medical correction action.
Study groups in NCT05715424
Study groupRoleWhat they receive
Cluster AExperimentalThe study population (school-based) was divided into four clusters.Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster A. The intervention was administered at month 6 and monitored for two years.
Receives: Other: Six interventions for children and adolescents
Cluster BExperimentalThe study population (school-based) was divided into four clusters. Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster B. The intervention was administered at month 12 and monitored for one and a half years.
Receives: Other: Six interventions for children and adolescents
Cluster CExperimentalThe study population (school-based) was divided into four clusters.Each cluster will receive the same intervention. and one cluster was randomly selected as Cluster C. The intervention was administered at month 18 and monitored for a continuous period of one year.
Receives: Other: Six interventions for children and adolescents
Cluster DExperimentalThe study population (school-based) was divided into four clusters.Each cluster will receive the same intervention.and one cluster was randomly selected as Cluster D. The intervention was implemented at month 18 and an evaluation of the effect of the intervention was performed.
Receives: Other: Six interventions for children and adolescents

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in questionnaire survey

    Questionnaires based on myopia prevention and control for children and adolescents, including a questionnaire on myopia in children and adolescents.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 years

  2. Changes in uncorrected vision within two years

    Uncorrected visual acuity (UCVA) was measured for the right eye, then the left eye, with a E Standard Logarithm Vision Acuity Chart (GB11533-2011) in 5-grade notation (5- LogMAR), with illumination of the chart around 500lx. If one of the eyes UCVA was less than 5.0, then tests with combined lenses were conducted among the poor eye-sighted for confirming the types of ametropia (normal, myopia, hyperopia or other eye diseases).All the measurements were recorded.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 years

  3. Changes in visual acuity in computer optometry

    Optometry Automated computerized optometry is performed by an optometrist. Automatic optometry instrument using desktop computer automatic optometry, equipment requirements should conform to the "ISO10342-2010 Ophthalmic instruments: Optometry" provisions.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 years

  4. Changes in visual acuity during dilated pupil optometry

    Between 5% and 10% of the participants were selected for Dilated pupil optometry.

    Measured: Baseline, 6 months, 1 year, 1.5 years, 2 years

Secondary outcomes (2)
  1. Eye protection diary

    Daily questionnaire based on the development of myopia prevention and control in children and adolescents.

    Measured: Three months.

  2. Qualitative interview

    Based on the interview outline on myopia prevention and control, some randomly selected students, parents, teachers and related departments were investigated.

    Measured: Baseline, 1 year, 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2023
  2. Study start1 Dec 2022
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
1,000,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05715424
Sponsor's protocol ID
20210735
Status last verified
Apr 2024
First submitted
10 Nov 2022
Last updated
9 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Six interventions for children and adolescents in people with Myopia and Refractive Errors, run by Anhui Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact FangBiao Tao, Professor (+86 19966513010, vipur8@outlook.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in questionnaire survey (time frame: Baseline, 6 months, 1 year, 1.5 years, 2 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05715424 | AzTrials